$37,727,154

Department of Health and Human Services·National Institutes of Health

biotechactiveONGOING · MOD OF 2020 CONTRACT

WORK BEGAN2020-08-31·LATEST ACTION2026-05-08·SOURCEUSASPENDING·SOURCE IDCONT_AWD_75N91020F00030_7529_75N91019D00024_7529

Award description

CPTAC BIOSPECIMEN COLLECTION

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Ongoing obligation for cancer biospecimen collection and management supporting NIH's Cancer Prevention and Treatment Centers.

Sub-sectors

cancer-researchbiospecimen-infrastructurenih-research-infrastructure

Why this matters

CPTAC biospecimens fund foundational cancer research infrastructure supporting U.S. drug discovery and clinical translation.

Supply-chain signal

Supports clinical research networks, diagnostic labs, and biospecimen logistics suppliers.

U.S.–China competition angle

Maintains U.S. cancer research infrastructure amid global biotech competition for advanced therapeutic development.

Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-06-14. Cost: $0.008083.

Period of performance

Start

2020-08-31

End

2027-08-30

Status

activein 426 days

Recipient

Other awards from this recipient

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier CONT_AWD_75N91020F00030_7529_75N91019D00024_7529.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.